Longbow Finance SA Reduces Position in McKesson Corporation $MCK

Longbow Finance SA lessened its position in McKesson Corporation (NYSE:MCK) by 13.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,680 shares of the company’s stock after selling 2,132 shares during the period. Longbow Finance SA’s holdings in McKesson were worth $10,568,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of MCK. IAM Advisory LLC increased its position in McKesson by 0.3% during the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after purchasing an additional 13 shares during the period. PDS Planning Inc boosted its stake in shares of McKesson by 1.1% during the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock valued at $934,000 after purchasing an additional 13 shares in the last quarter. Cardinal Point Capital Management ULC increased its position in shares of McKesson by 2.2% during the second quarter. Cardinal Point Capital Management ULC now owns 645 shares of the company’s stock valued at $473,000 after buying an additional 14 shares during the period. Goldstein Advisors LLC raised its stake in McKesson by 4.4% in the third quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock worth $258,000 after buying an additional 14 shares in the last quarter. Finally, Warren Street Wealth Advisors LLC lifted its holdings in McKesson by 4.9% in the third quarter. Warren Street Wealth Advisors LLC now owns 319 shares of the company’s stock worth $246,000 after buying an additional 15 shares during the period. 85.07% of the stock is owned by institutional investors.

Analysts Set New Price Targets

MCK has been the topic of a number of research analyst reports. Wells Fargo & Company upped their target price on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Robert W. Baird set a $968.00 price objective on McKesson in a research report on Wednesday, January 14th. UBS Group boosted their price objective on shares of McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and a consensus target price of $937.07.

McKesson Trading Down 3.9%

McKesson stock opened at $916.08 on Friday. McKesson Corporation has a 12 month low of $585.22 and a 12 month high of $971.93. The stock has a fifty day simple moving average of $837.61 and a two-hundred day simple moving average of $785.95. The firm has a market cap of $112.21 billion, a price-to-earnings ratio of 26.35, a PEG ratio of 1.53 and a beta of 0.40.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period last year, the firm posted $8.03 earnings per share. McKesson’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio is currently 9.43%.

Insider Buying and Selling

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.08% of the stock is currently owned by insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.